Menu
1-702-720-6310 info@microcapspecualtors.com

Boston biotech Albireo goes public in unusual fashion – The Boston Globe

Boston biotech Albireo goes public in unusual fashion
The Boston Globe
Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company, in a deal that will leave Albireo with about $30 million to develop a treatment for a pediatric liver disease.

and more »

Search